NanoTag Biotechnologies GmbH – Trademark Portfolio
Entity Type: 99
NanoTag Biotechnologies GmbH holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include FLUOTAG, NANOTAG, and SMART SECONDARIES. The owner is based in Goettingen.
Rudolf-Wissell-Str. 28
Goettingen 37079 , DE
Showing of trademarks Trademarks
Trademark Classifications
NanoTag Biotechnologies GmbH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does NanoTag Biotechnologies GmbH have?
NanoTag Biotechnologies GmbH has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 1 abandoned.
What trademark classes does NanoTag Biotechnologies GmbH file in?
NanoTag Biotechnologies GmbH files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are NanoTag Biotechnologies GmbH's most well-known trademarks?
NanoTag Biotechnologies GmbH's registered trademark portfolio includes well-known marks such as FLUOTAG, NANOTAG, and SMART SECONDARIES. These are among 3 currently registered trademarks in the portfolio.
What is NanoTag Biotechnologies GmbH's trademark registration success rate?
NanoTag Biotechnologies GmbH has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.